Decision Resources DRugwatch Blog Quick insight on intriguing drug market developments from Decision Resources’ analysts. <![CDATA[What to Expect at ASCO 2013]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/_CBQmbjlGbE" height="1" width="1"/> Fri, 24 May 2013 08:40:57 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/_CBQmbjlGbE/What-to-Expect-at-ASCO-052413 http://decisionresources.com/The-Decision-Resources-Blog/May-2013/What-to-Expect-at-ASCO-052413 <![CDATA[Surprising News from Heart Rhythm Society – There may be more life in Warfarin than we think]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/1j19pg1VGuA" height="1" width="1"/> Wed, 15 May 2013 17:12:10 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/1j19pg1VGuA/News-from-Heart-Rhythm-Society-051513 http://decisionresources.com/The-Decision-Resources-Blog/May-2013/News-from-Heart-Rhythm-Society-051513 <![CDATA[Nil Points in the European Drug Contest]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/C4qnagMfLik" height="1" width="1"/> Wed, 08 May 2013 12:36:31 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/C4qnagMfLik/Advantage-to-Canagliflozin-040313 http://decisionresources.com/The-Decision-Resources-Blog/May-2013/Advantage-to-Canagliflozin-040313 <![CDATA[The success of new agents for obesity is a safe bet. Or is it?]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/hwUAPTqj4ME" height="1" width="1"/> Wed, 01 May 2013 11:07:47 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/hwUAPTqj4ME/New-Agents-for-Obesity-050113 http://decisionresources.com/The-Decision-Resources-Blog/May-2013/New-Agents-for-Obesity-050113 <![CDATA[Grand Slam for Eli Lilly but Can Dulaglutide Break into the Diabetes Market?]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/KTtd4l6C8Uw" height="1" width="1"/> Wed, 24 Apr 2013 10:55:01 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/KTtd4l6C8Uw/Grand-Slam-for-Eli-Lilly-042413 http://decisionresources.com/The-Decision-Resources-Blog/April-2013/Grand-Slam-for-Eli-Lilly-042413 <![CDATA[Oral Insulin – Will it offer the cost reductions some believe?]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/Jxpcn07-aNk" height="1" width="1"/> Mon, 15 Apr 2013 14:18:52 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/Jxpcn07-aNk/Oral-Insulin-041513 http://decisionresources.com/The-Decision-Resources-Blog/April-2013/Oral-Insulin-041513 <![CDATA[A CHMP Decision for Belviq is Coming Soon—High Stakes for Arena, But Will It Matter?]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/66w_PqO-kMk" height="1" width="1"/> Mon, 08 Apr 2013 14:52:02 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/66w_PqO-kMk/CHMP-Decision-for-Belviq-is-Coming-Soon-040813 http://decisionresources.com/The-Decision-Resources-Blog/April-2013/CHMP-Decision-for-Belviq-is-Coming-Soon-040813 <![CDATA[Live from NKF: SGLT2s Use in CKD]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/J32vIfuyn4Q" height="1" width="1"/> Thu, 04 Apr 2013 12:57:37 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/J32vIfuyn4Q/Live-from-NKF-040413 http://decisionresources.com/The-Decision-Resources-Blog/April-2013/Live-from-NKF-040413 <![CDATA[Advantage to canagliflozin (Invokana) in the SGLT-2 inhibitor race]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/6bD7WGXWrc4" height="1" width="1"/> Wed, 03 Apr 2013 15:04:06 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/6bD7WGXWrc4/Advantage-to-Canagliflozin-040313 http://decisionresources.com/The-Decision-Resources-Blog/April-2013/Advantage-to-Canagliflozin-040313 <![CDATA[FDA Issues Second Complete Response Letter for Janssen/Bayer’s rivaroxaban (Xarelto) in ACS]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/AWLKXSgCG4g" height="1" width="1"/> Wed, 06 Mar 2013 08:31:48 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/AWLKXSgCG4g/FDA-Response-to-Xarelto-030613 http://decisionresources.com/The-Decision-Resources-Blog/March-2013/FDA-Response-to-Xarelto-030613 <![CDATA[T-DM1 Approval – A Victory for Roche and Antibody-Drug Conjugates]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/Ej5rR3KWs1o" height="1" width="1"/> Thu, 28 Feb 2013 16:45:17 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/Ej5rR3KWs1o/T-DM1-Approval-022813 http://decisionresources.com/The-Decision-Resources-Blog/February-2013/T-DM1-Approval-022813 <![CDATA[The Fall of Another ESA – Takeda and Affymax Recall Omontys from the US Market]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/QQ6DOHdqM8Y" height="1" width="1"/> Wed, 27 Feb 2013 08:33:05 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/QQ6DOHdqM8Y/Fall-of-Another-ESA-022713 http://decisionresources.com/The-Decision-Resources-Blog/February-2013/Fall-of-Another-ESA-022713 <![CDATA[FDA Getting Tougher on Diabetes Drugs? ]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/C7-aKc3HNas" height="1" width="1"/> Tue, 19 Feb 2013 16:17:26 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/C7-aKc3HNas/FDA-Tougher-on-Diabetes-Drugs-021913 http://decisionresources.com/The-Decision-Resources-Blog/February-2013/FDA-Tougher-on-Diabetes-Drugs-021913 <![CDATA[Competitive Headwinds: the Beginning of the Kynamro and Juxtapid Story]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/7vRMsOjkEfQ" height="1" width="1"/> Thu, 07 Feb 2013 16:47:46 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/7vRMsOjkEfQ/the-Kynamro-and-Juxtapid-020713 http://decisionresources.com/The-Decision-Resources-Blog/February-2013/the-Kynamro-and-Juxtapid-020713 <![CDATA[Stemline Therapeutics IPO: A new chapter in biotech investments]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/9XmtW8C71LU" height="1" width="1"/> Thu, 31 Jan 2013 15:01:55 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/9XmtW8C71LU/Stemline-Therapeutics-IPO-013113 http://decisionresources.com/The-Decision-Resources-Blog/January-2013/Stemline-Therapeutics-IPO-013113 <![CDATA[Biosimilars: States Forge Ahead While Awaiting FDA Action]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/qDvfk2CzWVM" height="1" width="1"/> Thu, 24 Jan 2013 15:53:38 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/qDvfk2CzWVM/States-Await-FDA-Action-012413 http://decisionresources.com/The-Decision-Resources-Blog/January-2013/States-Await-FDA-Action-012413 <![CDATA[The New Abbott and Pfizer]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/jhiob5hN5Fo" height="1" width="1"/> Tue, 22 Jan 2013 15:05:42 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/jhiob5hN5Fo/The-New-Abbott-and-Pfizer-012213 http://decisionresources.com/The-Decision-Resources-Blog/January-2013/The-New-Abbott-and-Pfizer-012213 <![CDATA[Cancer Drug Pricing Strategies: What Can We Learn from Sanofi’s Zaltrap and Exelixis’s Cometriq?]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/GaPDvNuYaM0" height="1" width="1"/> Wed, 16 Jan 2013 11:05:31 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/GaPDvNuYaM0/Cancer-Drug-Pricing-Strategies-011613 http://decisionresources.com/The-Decision-Resources-Blog/January-2013/Cancer-Drug-Pricing-Strategies-011613 <![CDATA[J&J’s Sirturo Approved against Multidrug-Resistant Tuberculosis ]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/LnWwA13__RQ" height="1" width="1"/> Thu, 10 Jan 2013 13:21:00 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/LnWwA13__RQ/Johnson-and-Johnsons-Sirturo-TB-011013 http://decisionresources.com/The-Decision-Resources-Blog/January-2013/Johnson-and-Johnsons-Sirturo-TB-011013 <![CDATA[Key Healthcare Market Events 2012: Tentative Advancement for Alzheimer’s Treatment]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/SICYvU-G9f0" height="1" width="1"/> Fri, 21 Dec 2012 09:29:18 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/SICYvU-G9f0/Key-Events-2012-Alzheimers-Treatment-122112 http://decisionresources.com/The-Decision-Resources-Blog/December-2012/Key-Events-2012-Alzheimers-Treatment-122112 <![CDATA[Key Healthcare Market Events 2012: Recent Advances to Curb the Impact of Cardiovascular Disease]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/upJh1wJkzOk" height="1" width="1"/> Thu, 20 Dec 2012 08:53:28 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/upJh1wJkzOk/Key-Events-2012-Advances-in-Cardio-122012 http://decisionresources.com/The-Decision-Resources-Blog/December-2012/Key-Events-2012-Advances-in-Cardio-122012 <![CDATA[Key Healthcare Market Events 2012: It’s About Time – Release of FDA Draft Guidelines for Biosimilars]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/JwRqq0A1usA" height="1" width="1"/> Wed, 19 Dec 2012 09:31:22 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/JwRqq0A1usA/Key-Events-2012-Biosimilars-FDA-Guidelines-121912 http://decisionresources.com/The-Decision-Resources-Blog/December-2012/Key-Events-2012-Biosimilars-FDA-Guidelines-121912 <![CDATA[Key Healthcare Market Events 2012: Healthcare Reform is Here to Stay]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/Mdhb1orPsk8" height="1" width="1"/> Tue, 18 Dec 2012 08:30:43 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/Mdhb1orPsk8/Key-Events-2012-Healthcare-Reform-121812 http://decisionresources.com/The-Decision-Resources-Blog/December-2012/Key-Events-2012-Healthcare-Reform-121812 <![CDATA[Key Healthcare Market Events 2012: Belviq and Qsymia: Weight Loss Game-Changers]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/0E-lIDWs64s" height="1" width="1"/> Mon, 17 Dec 2012 11:33:52 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/0E-lIDWs64s/Key-Events-2012-Belviq-and-Qsymia-121712 http://decisionresources.com/The-Decision-Resources-Blog/December-2012/Key-Events-2012-Belviq-and-Qsymia-121712 <![CDATA[Trastuzumab to be incorporated into the Brazilian National Health System – A Much Desired Boost to the Breast Cancer Armamentarium]]> <img src="http://feeds.feedburner.com/~r/decisionresources/hOcl/~4/z5hjMvryS6Q" height="1" width="1"/> Wed, 01 Aug 2012 13:37:51 GMT http://feedproxy.google.com/~r/decisionresources/hOcl/~3/z5hjMvryS6Q/Trastuzumab-Brazil-080112 http://decisionresources.com/The-Decision-Resources-Blog/August-2012/Trastuzumab-Brazil-080112